why choose us

First received: May 03, 2024

Clinical Trial: InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type 1 Diabetes Mellitus

Study Type: INTERVENTIONAL


Official Title: Feasibility of a Bolus Calculator Without Carbohydrate Counting in Type 1 Diabetes Patients Under Multiple Daily Injections (MDI) Therapy: A Supervised Randomized Controlled Trial.

Brief Summary: This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention.In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection period.

Read more